124 related articles for article (PubMed ID: 16708050)
1. Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans.
Lamba JK; Chen X; Lan LB; Kim JW; Wei Wang X; Relling MV; Kazuto Y; Watkins PB; Strom S; Sun D; Schuetz JD; Schuetz EG
Pharmacogenet Genomics; 2006 Jun; 16(6):415-27. PubMed ID: 16708050
[TBL] [Abstract][Full Text] [Related]
2. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.
Zimonjic DB; Durkin ME; Keck-Waggoner CL; Park SW; Thorgeirsson SS; Popescu NC
Neoplasia; 2003; 5(5):390-6. PubMed ID: 14670176
[TBL] [Abstract][Full Text] [Related]
3. Infrequent amplification of JUN in hepatocellular carcinoma.
Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
[TBL] [Abstract][Full Text] [Related]
4. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
5. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma.
Tsuji K; Yasui K; Gen Y; Endo M; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Apr; 198(2):118-25. PubMed ID: 20362226
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of genes associated with human hepatocellular carcinogenesis.
Kondoh N; Wakatsuki T; Ryo A; Hada A; Aihara T; Horiuchi S; Goseki N; Matsubara O; Takenaka K; Shichita M; Tanaka K; Shuda M; Yamamoto M
Cancer Res; 1999 Oct; 59(19):4990-6. PubMed ID: 10519413
[TBL] [Abstract][Full Text] [Related]
7. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
[TBL] [Abstract][Full Text] [Related]
8. Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.
Yung MK; Lo KW; Yip CW; Chung GT; Tong CY; Cheung PF; Cheung TT; Poon RT; So S; Fan ST; Cheung ST
BMC Cancer; 2015 Apr; 15():264. PubMed ID: 25885205
[TBL] [Abstract][Full Text] [Related]
9. Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients.
Flannery PC; Abbott KL; Pondugula SR
Eur J Drug Metab Pharmacokinet; 2020 Apr; 45(2):297-304. PubMed ID: 31792727
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor expression and gene copy number in fibrolamellar hepatocellular carcinoma.
Buckley AF; Burgart LJ; Kakar S
Hum Pathol; 2006 Apr; 37(4):410-4. PubMed ID: 16564914
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
[TBL] [Abstract][Full Text] [Related]
12. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
[TBL] [Abstract][Full Text] [Related]
13. Assessment of differentiation and progression of hepatic tumors using array-based comparative genomic hybridization.
Steinemann D; Skawran B; Becker T; Tauscher M; Weigmann A; Wingen L; Tauscher S; Hinrichsen T; Hertz S; Flemming P; Flik J; Wiese B; Kreipe H; Lichter P; Schlegelberger B; Wilkens L
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1283-91. PubMed ID: 16979954
[TBL] [Abstract][Full Text] [Related]
14. [Loss of p53 gene and amplification of HER-2 oncogene in primary hepatocellular carcinoma and their clinical significance].
Huang BJ; Zhu ZY; Liang QW; Fang Y
Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):20-4. PubMed ID: 12760798
[TBL] [Abstract][Full Text] [Related]
15. Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon.
Shinomiya T; Mori T; Ariyama Y; Sakabe T; Fukuda Y; Murakami Y; Nakamura Y; Inazawa J
Genes Chromosomes Cancer; 1999 Apr; 24(4):337-44. PubMed ID: 10092132
[TBL] [Abstract][Full Text] [Related]
16. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver.
Iwahori T; Matsuura T; Maehashi H; Sugo K; Saito M; Hosokawa M; Chiba K; Masaki T; Aizaki H; Ohkawa K; Suzuki T
Hepatology; 2003 Mar; 37(3):665-73. PubMed ID: 12601364
[TBL] [Abstract][Full Text] [Related]
17. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas.
Okamoto H; Yasui K; Zhao C; Arii S; Inazawa J
Hepatology; 2003 Nov; 38(5):1242-9. PubMed ID: 14578863
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification and expression in lung cancer cells with acquired paclitaxel resistance.
Yabuki N; Sakata K; Yamasaki T; Terashima H; Mio T; Miyazaki Y; Fujii T; Kitada K
Cancer Genet Cytogenet; 2007 Feb; 173(1):1-9. PubMed ID: 17284363
[TBL] [Abstract][Full Text] [Related]
19. Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.
Rodríguez-Antona C; Leskelä S; Zajac M; Cuadros M; Alvés J; Moneo MV; Martín C; Cigudosa JC; Carnero A; Robledo M; Benitez J; Martínez-Delgado B
Blood; 2007 Nov; 110(9):3345-51. PubMed ID: 17634410
[TBL] [Abstract][Full Text] [Related]
20. NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma.
Zhang ZZ; Huang J; Wang YP; Cai B; Han ZG
Int J Cancer; 2015 Aug; 137(4):765-75. PubMed ID: 25612832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
